Latest News and Press Releases

Tourmaline Bio Highlights Cardiovascular Inflammation Focus and Announces Key Clinical and Strategic Updates at Investor Day

Tourmaline Bio to Host Investor Day on Tuesday, December 10, 2024

Tourmaline Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Tourmaline Bio to Present at Upcoming Investor Conferences

Tourmaline Bio to Host Expert Webinar on Human Genetic Validation for IL-6 Inhibition in Cardiovascular Disease with Dr. Dipender Gill on Friday, November

Tourmaline Bio to Showcase Two Poster Presentations at the 2024 Cardiometabolic Health Congress

Tourmaline Bio Announces Formation of Cardiovascular Scientific Advisory Board

Tourmaline Bio to Present at Upcoming Investor Conferences

Tourmaline Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Tourmaline Bio Presents Phase 2 TRANQUILITY Study Design at American Society of Preventive Cardiology (ASPC) Congress 2024